Skip to main content
OpenTrials

Clinical trial condition

Neurofibromatosis 1

Explore clinical trials studying Neurofibromatosis 1. Study availability and eligibility vary by location and protocol.

133 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Neurofibromatosis 1 trial results

Completed

SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors

NCT03433183

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosarcoma, Genetic Diseases, Inborn, +22 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • National Cancer Institute Bethesda, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

NCT05005845

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cutaneous Neurofibroma, Genetic Diseases, Inborn, +14 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Northwest Arkansas Clinical Trials Center, PLLC Rogers, Arkansas, United States
  • Center for Dermatology Clinical Research, Inc. Fremont, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 23 locations
View Trial Details

Related conditions